94 related articles for article (PubMed ID: 8539932)
1. Early changes in syngeneic islet grafts: effect of recipient's metabolic control on graft outcome.
Davalli AM; Scaglia L; Zangen DH; Hollister J; Bonner-Weir S; Weir GC
Transplant Proc; 1995 Dec; 27(6):3238-9. PubMed ID: 8539932
[No Abstract] [Full Text] [Related]
2. Syngeneic islet transplantations into the submandibular gland of mice.
Sandberg M; Carlsson F; Nilsson B; Korsgren O; Carlsson PO; Jansson L
Transplantation; 2011 Jan; 91(2):e17-9. PubMed ID: 21239961
[No Abstract] [Full Text] [Related]
3. Beta-cell replication in long-term transplanted islets.
Montaña E; Nacher V; Soler J
Transplant Proc; 1995 Dec; 27(6):3201. PubMed ID: 8539913
[No Abstract] [Full Text] [Related]
4. Beta cell replication at five months after syngeneic islet transplantation.
Nacher V; Soler J; Montaña E
Transplant Proc; 1995 Aug; 27(4):2359. PubMed ID: 7652840
[No Abstract] [Full Text] [Related]
5. Effect of cryopreservation on islet recovery and in vivo function.
Cattral MS; Lakey JR; Warnock GL; Kneteman NM; Rajotte RV
Transplant Proc; 1995 Dec; 27(6):3336. PubMed ID: 8539978
[No Abstract] [Full Text] [Related]
6. Hyperoxia improves the survival of intraportally transplanted syngeneic pancreatic islets.
Hughes SJ; Davies SE; Powis SH; Press M
Transplantation; 2003 Jun; 75(12):1954-9. PubMed ID: 12829893
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of pancreas graft function by the measurement of pancreatic protein synthesis rate.
Miyauchi H; Asano T; Uematsu T; Nakagohri T; Hasegawa M; Maruyama M; Iwashita T; Isono K
Transplant Proc; 1996 Feb; 28(1):361-2. PubMed ID: 8644264
[No Abstract] [Full Text] [Related]
8. Surviving native beta-cells determine outcome of syngeneic intraportal islet transplantation.
Hughes SJ; Powis SH; Press M
Cell Transplant; 2001; 10(2):145-51. PubMed ID: 11332628
[TBL] [Abstract][Full Text] [Related]
9. Protection of mouse islet isografts from early transplantation damage by nicotinamide treatment of recipients.
Kenmochi T; Mullen Y; Miyamoto M; Stein E
Transplant Proc; 1994 Apr; 26(2):693. PubMed ID: 8171611
[No Abstract] [Full Text] [Related]
10. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device.
Pileggi A; Molano RD; Ricordi C; Zahr E; Collins J; Valdes R; Inverardi L
Transplantation; 2006 May; 81(9):1318-24. PubMed ID: 16699461
[TBL] [Abstract][Full Text] [Related]
11. Fifty islets maintain euglycemia and survive longer than 200 islets in allogeneic and xenogeneic diabetic hosts.
Ohzato H; Porter J; Monaco AP; Maki T
Transplant Proc; 1993 Feb; 25(1 Pt 2):953-4. PubMed ID: 8442277
[No Abstract] [Full Text] [Related]
12. Improvement in allograft survival of islets of Langerhans by pretreatment with deoxyguanosine.
al-Abdullah IH; Kumar MS; al-Adnani MS; Abouna GM
Diabetes Res; 1991 Aug; 17(4):181-7. PubMed ID: 1823639
[TBL] [Abstract][Full Text] [Related]
13. Consistent long-term allograft survival in murine pancreatic islet transplants without immunosuppression.
Jain K; Cai BR; Patel S; Yang H; Smith BH; Suthanthiran M; Rubin AL
Transplant Proc; 1994 Dec; 26(6):3492-3. PubMed ID: 7998243
[No Abstract] [Full Text] [Related]
14. Islet protective effect of pravastatin from nonspecific inflammation in mouse pancreatic islet isografts.
Arita S; Saul J; Joh S; Kasraie A; Atiya A; Une S; Ohtsuka S; Mullen Y
Transplant Proc; 1996 Apr; 28(2):924. PubMed ID: 8623465
[No Abstract] [Full Text] [Related]
15. Dose dependence of bacillus Calmette-Guerin on the prevention of autoimmune diabetes in syngeneic islet transplantation.
Lakey JR; Singh B; Warnock GL; Elliott JF; Rajotte RV
Transplant Proc; 1995 Dec; 27(6):3413. PubMed ID: 8540025
[No Abstract] [Full Text] [Related]
16. Permanent acceptance of mitomycin C-treated islet allograft.
Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
[TBL] [Abstract][Full Text] [Related]
17. The role of macrophage migration inhibitory factor in mouse islet transplantation.
Toso C; Serre-Beinier V; Emamaullee J; Merani S; Armanet M; Wojtusciszyn A; Bosco D; Calandra T; Roger T; Morel P; Shapiro AM; Berney T
Transplantation; 2008 Nov; 86(10):1361-9. PubMed ID: 19034004
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiogenesis is associated with reduced islet engraftment in diabetic recipient mice.
Zhang N; Qu S; Xu J; Bromberg JS; Dong HH
Transplant Proc; 2005 Dec; 37(10):4452-7. PubMed ID: 16387144
[TBL] [Abstract][Full Text] [Related]
19. Protection of intrahepatic islet grafts from hyperglycemic toxicity by nicotinamide treatment.
Ueki M; Yasunami Y; Arima T; Motoyama K; Ikeda S; Tanaka M
Transplant Proc; 1995 Feb; 27(1):618. PubMed ID: 7879121
[No Abstract] [Full Text] [Related]
20. Protective effects of nicotinamide on renal subcapsular islet isografts with a marginal mass from sustained hyperglycemia in the streptozotocin-induced diabetic rats.
Nagai T; Yasunami Y; Nagata N; Ueki M; Ono J; Ikeda S
Transplant Proc; 1995 Dec; 27(6):3196-7. PubMed ID: 8539910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
